- Investing Ideas
- Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Argentinian Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
17
Companies with a Value score of at least 3, ordered by Value score
17 companies
Gilead Sciences
Market Cap: AR$165.2b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
AR$52,825.00
7D
2.7%
1Y
32.6%
Bristol-Myers Squibb
Market Cap: US$132.2b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMYD
US$22.50
7D
0.6%
1Y
47.5%
Bristol-Myers Squibb
Market Cap: AR$131.0b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY
AR$34,100.00
7D
-0.9%
1Y
66.7%
Amgen
Market Cap: US$222.2b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGND
US$14.03
7D
4.6%
1Y
50.9%
Bayer
Market Cap: AR$22.5b
Operates as a life science company worldwide.
BAYN
AR$3,323.26
7D
0%
1Y
n/a
Novo Nordisk
Market Cap: US$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVOD
US$7.00
7D
0.1%
1Y
n/a
Amgen
Market Cap: AR$222.2b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN
AR$21,640.00
7D
6.8%
1Y
69.4%
Novo Nordisk
Market Cap: AR$1.3t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NVO
AR$10,660.00
7D
0.5%
1Y
n/a
GSK
Market Cap: US$78.6b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKD
US$13.75
7D
2.0%
1Y
49.6%
Gilead Sciences
Market Cap: US$165.2b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILDD
US$33.83
7D
0.6%
1Y
12.4%
GSK
Market Cap: AR$78.6b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
AR$20,980.00
7D
2.6%
1Y
65.8%
AstraZeneca
Market Cap: AR$184.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
AR$63,825.00
7D
-4.7%
1Y
30.2%
Tempus AI
Market Cap: AR$9.4b
Operates as a healthcare technology company in the United States.
TEM
AR$6,890.00
7D
19.4%
1Y
2.2%
Novartis
Market Cap: AR$239.5b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS
AR$61,925.00
7D
0.5%
1Y
59.2%
Novartis
Market Cap: US$239.5b
Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVSD
US$40.50
7D
-1.1%
1Y
35.9%
AstraZeneca
Market Cap: US$184.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZND
US$41.67
7D
-7.7%
1Y
12.0%
Tempus AI
Market Cap: US$9.4b
Operates as a healthcare technology company in the United States.
TEMD
US$4.45
7D
17.0%
1Y
n/a